Furthermore, heart explants from DCM patients exhibit increased expression of different ERS markers such as ATF6, GRP78 or XBP1 compared to controls demonstrating the activation of ERS and UPR pathways in DCM patients [30]. This evidence concerns the gene XBP1 and familial dilated cardiomyopathy.